Zika Virus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults
Conditions:   Zika Virus;   Zika Virus Infection Interventions:   Biological: VLA1601;   Biological: Placebo Sponsors:   Valneva Austria GmbH;   Emergent BioSolutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials